ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag tuberculosis biotech clinical trials drug development genetics genomics

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
A gloved hand holds a tweezer and pulls a section of DNA away from a double helix
First Person Dosed in Novel Gene Editing Clinical Trial
Amanda Heidt | Jul 12, 2022 | 4 min read
The biotech company Verve Therapeutics launched the study with the aim of using base editing to treat a genetic condition that causes high cholesterol and increases a person's risk of developing cardiovascular disease.
Companies Create New Antisense Drugs As Clinical Trials Progress
Alison Mack | Dec 8, 1996 | 8 min read
Sidebar: Further Information - Companies Creating Antisense Drugs BROADENED FOCUS: Shaji George says an equal number of biologists and chemists make up Innovir Laboratories' research team. Embracing the idea that tomorrow's drugs will not merely treat symptoms, but also attack disease-causing genes, scores of biotechnology companies are developing compounds to intervene in the cell's genetic machinery. One focus of this activity is antisense therapeutics: the use of synthetic nucleic acids de
Learning from Iceland’s Model for Genetic Research
Catherine Offord | Jun 1, 2017 | 8 min read
The Scandinavian island’s unique combination of genetic homogeneity, genealogical tradition, and high participation in research make it a prime location for discovery and validation of drug targets.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Gene Therapy for Sickle Cell Not Linked to Cancer, Bluebird Finds
Lisa Winter | Mar 11, 2021 | 2 min read
Clinical trials were halted after the treatment’s vector that ferries in the healthy genetic sequence was identified in the genome of a patient’s cancer cells.
Humans Inoculated with Genetically Modified Malaria Parasites
Ruth Williams | May 20, 2020 | 4 min read
Engineered Plasmodium parasites form the basis of two experimental malaria vaccines that showed safety and encouraging immune responses in clinical trials.
Composite image showing genes radiating from tumor cells
Jumping Genes’ Role in Cancer
Diana Kwon | Mar 1, 2023 | 8 min read
Transposons may be key players in how tumors develop and spread, but they also keep cancer at bay in some circumstances.
Recent Trials for Fragile X Syndrome Offer Hope
Randi Hagerman | Sep 1, 2019 | 10+ min read
Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.
Gene-Edited Pets
Karen Zusi | Oct 2, 2015 | 2 min read
Genomics giant BGI announces plans to sell “micro-pigs” it originally developed for research.

Run a Search

ADVERTISEMENT